Rasbach Kyle

Rasbach Kyle is listed in filings as Chief Financial Officer at Lexeo Therapeutics, Inc. Common Stock. This profile follows SEC Form 4 activity through Jan 22, 2025, including 2 public disclosures. Recent filings connect the profile to Lexeo Therapeutics, Inc. Common Stock (LXEO). The current snapshot covers public activity from Jan 22, 2025. Reported amounts are shown as $1.2M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.